ConductScience.org, home

Paper39149579

A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects.

Adam AS and 4 others. Psychedelic Med (New Rochelle), 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects. Papers, record 39149579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39149579

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects.
PubMed
Journal
Psychedelic Med (New Rochelle)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.29, provisional
iCite
Revised in PubMed
2025-07-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adam ASAbshir S
2LaMalfa KSKayleigh S
3Razavi YYasaman
4Kohut SJStephen J
5Kangas BDBrian Dhttps://orcid.org/0000-0002-4597-9801

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DA048150NIDA NIH HHSUnited StatesR01DA048150PubMed

Source NIH RePORTER

Download CSV of grants

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115705346Toward an objective characterization of an anhedonic phenotype: a signal-detection approach.Biol Psychiatry2005https://conductscience.org/library/papers/15705346PubMed
234921225A cross-species assay demonstrates that reward responsiveness is enduringly impacted by adverse, unpredictable early-life experiences.Neuropsychopharmacology2022https://conductscience.org/library/papers/34921225PubMed
318726908Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function.Hum Brain Mapp2009https://conductscience.org/library/papers/18726908PubMed
435341568Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals.Adv Pharmacol2022https://conductscience.org/library/papers/35341568PubMed
535040425Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review - CORRIGENDUM.BJPsych Open2022https://conductscience.org/library/papers/35040425PubMed
616508761Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected.Psychopharmacology (Berl)2007https://conductscience.org/library/papers/16508761PubMed
733852780Trial of Psilocybin versus Escitalopram for Depression.N Engl J Med2021https://conductscience.org/library/papers/33852780PubMed
821289169Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices.J Neurosci2011https://conductscience.org/library/papers/21289169PubMed
933146667Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA Psychiatry2021https://conductscience.org/library/papers/33146667PubMed
1027909165Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.J Psychopharmacol2016https://conductscience.org/library/papers/27909165PubMed
1132777649Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies.J Affect Disord2020https://conductscience.org/library/papers/32777649PubMed
1233280005Translational Assessments of Reward Responsiveness in the Marmoset.Int J Neuropsychopharmacol2021https://conductscience.org/library/papers/33280005PubMed
1332792526Empirical validation of a touchscreen probabilistic reward task in rats.Transl Psychiatry2020https://conductscience.org/library/papers/32792526PubMed
1432871534Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression.J Affect Disord2020https://conductscience.org/library/papers/32871534PubMed
1534727422Effects of Ketamine Versus Midazolam on Neurocognition at 24 Hours in Depressed Patients With Suicidal Ideation.J Clin Psychiatry2021https://conductscience.org/library/papers/34727422PubMed
1619373443Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.Mol Neurobiol2009https://conductscience.org/library/papers/19373443PubMed
1721279163Titrating-delay matching-to-sample in the pigeon.J Exp Anal Behav2010https://conductscience.org/library/papers/21279163PubMed
1818520604Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.Ther Drug Monit2008https://conductscience.org/library/papers/18520604PubMed
1933711169Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse.J Neurochem2021https://conductscience.org/library/papers/33711169PubMed
2025374095Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.Neuropsychopharmacology2015https://conductscience.org/library/papers/25374095PubMed

See all 80 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
41354763ENX-104: a selective and potent D2/D3 receptor antagonist enhances dopamine neurotransmission and reward responsiveness in translational rodent models.Neuropsychopharmacology2026https://conductscience.org/library/papers/41354763PubMed
41121647History, pharmacology and therapeutic mechanisms of 3,4-methylenedioxymethamphetamine (MDMA).Br J Pharmacol2026https://conductscience.org/library/papers/41121647PubMed
40288209Environmental determinants of ketamine's prohedonic and antianhedonic efficacy: Persistence of enhanced reward responsiveness is modulated by chronic stress.J Pharmacol Exp Ther2025https://conductscience.org/library/papers/40288209PubMed
39068642Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile "the great entactogen-empathogen debate".J Psychopharmacol2024https://conductscience.org/library/papers/39068642PubMed
38922872Chronic ecologically relevant stress effects on reverse-translated touchscreen assays of reward responsivity and attentional processes in male rats: Implications for depression.J Neurochem2024https://conductscience.org/library/papers/38922872PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39149579

GET https://conductscience.org/api/papers/v1/39149579/references?page=2